Business Context and Reporting Period
Company: Gyrodyne, LLC (GYRO)
Filing Type: Form 8-K (Current Report)
Date of Report: August 29, 2019
Reporting Period: The filing reports on a material definitive agreement executed on August 27, 2019, regarding the sale of a portion of the Company's Gyrodyne/Flowerfield complex in Smithtown, New York. The Company is currently in the process of liquidation.
Key Financial Metrics
Transaction Value: $16,800,000 purchase price for an approximately 9.0-acre parcel of vacant land.
Net Asset Value (NAV) Impact:
- Previous NAV (June 30, 2019): $17.82 per common share.
- Estimated NAV Increase from Sale: $4.10 per share.
- Estimated Expense Reserve Increase: $1.72 per share (due to extended liquidation timeline).
- Net NAV Increase: $2.38 per share.
- Revised Estimated NAV: $20.20 per common share.
Liquidity and Cash Flow: The filing does not provide specific cash flow statements, balance sheet totals, or debt figures. The transaction is contingent on regulatory approvals and has not yet closed.
Material Changes
The primary material change is the execution of a Purchase and Sale Agreement for the sale of the Property to BSL St. James LLC. This transaction is expected to:
- Increase the estimated Net Asset Value per share by $2.38.
- Extend the estimated liquidation timeline by 18 months due to the pursuit of entitlements related to the Property and adjacent parcels.
- Increase the expense reserve per share by $1.72 to account for the extended timeline.
Guidance, Outlook, and Risks
Outlook: Management anticipates the closing will raise NAV to $20.20 per share, pending the satisfaction of contingencies. The Company is contemplating measures to contain costs and reduce operating expenses in the later stages of dissolution.
Contingencies and Conditions: The agreement is subject to:
- An investigation period during which the buyer may terminate.
- Receipt of Subdivision Approval from the Town of Smithtown.
- Receipt of Site Plan Approval.
- Failure to obtain approvals within specified timeframes grants both parties the right to terminate the agreement.
Risks: The filing highlights risks that proceeds from asset sales may be substantially below estimates, insufficient to satisfy creditor obligations, or impacted by unforeseeable expenses. Additional risks include the tax treatment of condemnation proceeds and economic conditions in Suffolk and Westchester Counties, New York.
Investor Verification Checklist
- Verify the status of the Subdivision Approval and Site Plan Approval required for the $16.8 million sale to close.
- Confirm the revised liquidation timeline and the specific costs included in the increased $1.72 per share expense reserve.
- Monitor the Company's ability to contain operating expenses during the extended 18-month liquidation period.
- Review the full text of the Purchase and Sale Agreement (Exhibit 10.1) for specific termination rights and extension fees.